Arabian Healthcare Group teams up with CommonSpirit Health

CommonSpirit Health and Arabian Healthcare Group align to bring a new level of healthcare to UAE patients

CommonSpirit Health, a U.S. healthcare provider, has teamed up with Arabian Healthcare Group, to expand its growing healthcare sector, in the Emirate of Ras Al Khaimah, UAE.


The only healthcare institution in MENA to be aligned with Dignity Health International

Across all of the Middle East and North Africa, it is AHG’s forerunner, the RAK Hospital, which is the sole institution in the region to be teamed with CommonSpirit’s international health representative, Dignity Health International (DHI), a healthcare advisory and management service. Its presence makes the RAK the top desired medical station of choice for international patients across MENA, as well as locals. 

CommonSpirit utilises digital innovation, training, care coordination and network expansion to create a better patient experience, across its 140 hospitals and 1,500 care sites, in over 21 U.S. states. Specifically, CommonSpirit has a strong desire to support patients in the following categories:

  • Cardiac 
  • Orthopaedics
  • Neuroscience
  • Musculoskeletal 
  • Rehabilitation

This planned expansion will permit regional patients to have fully coordinated care, as well as access to the clinical expertise of Dignity Health International’s doctors. DHI’s network hospitals also use up-to-date digital and smart health resources. Additional artificial intelligence and telehealth services will be added to support the expansion requirements.


Designing a destination hospital for local and international patients

The design process has already begun for the expansion, which is in line with DHI’s best practises and protocols. Doctors in Ras Al Khaimah are ready to provide patients in the region with U.S. expertise.

“RAK Hospital was designed to be a destination hospital for both local and international patients, with its specialised surgical capabilities and best-in-class facilities”, said Dr. Raza Siddiqui, Executive Director of RAK Hospital and Arabian Healthcare Group CEO. “Our scalable model allowed us to first win the trust and confidence of the local community and then gain immense popularity with regional and international patients. This natural progression has led to the creation of our unique relationship with CommonSpirit.”

RAK Hospital will triple its capacity to become a 200-bed facility by the end of 2024. This will enable staff to cater to the increasing influx of medical tourists expected in the United Arab Emirates, as well as to meet the increased demand for quality health care which will be created by implementation of mandatory health insurance in the Northern Emirates. 

“The expansion will equip us to serve local and international patients with high-quality care”, said Dr Raza proudly. 

"We look forward to expanding our current working relationship with AHG,” said Gregg Davis, CommonSpirit’s system senior vice president and chief administrative officer for DHI. “This collaboration will align our physicians and nurses with providers from AHG, enhancing clinical capabilities available for patients within the MENA region and, ultimately, impacting patient outcomes.”

Share

Featured Articles

PA Consulting: People Want 'Stackable' Healthcare Products

PA Consulting report shows people want ‘stackable’ personalised healthcare products and services that leverage personal data

HIV Testing Landmark Highlights Ongoing AIDS Problems

As US healthcare solutions specialist RMI passes the 350-million HIV testing kit mark, we look at the current HIV/AIDS situation globally

Schneider's Blum on Electricity 4.0 and Healthcare

Olivier Blum, EVP of Schneider Electric’s Energy Management business tells Healthcare Digital how Electricity 4.0 can improve people's wellbeing

Research Breakthrough Promises New Lupus Treatments

Medical Devices & Pharma

Healthcare Systems Worldwide Hit by Global IT Outage

Technology & AI

Abbott Labs' profits soar; Nipro opens First US Facility

Medical Devices & Pharma